NCT01508247View on ClinicalTrials.gov

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months

PHASE3CompletedINTERVENTIONAL
Enrollment

10,245

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Hand, Foot and Mouth DiseaseHerpanginaOther EV71-associated Diseases
Interventions
BIOLOGICAL

inactivated vaccine (Vero Cell) against EV71

inactivated vaccine (vero cell) against EV71, 320U /0.5ml, two doses, on day0, 28

BIOLOGICAL

0/0.5ml placebo

0/0.5ml placebo, two doses, on day0, 28

Trial Locations (4)

Unknown

Donghai County Center for Disease Control and Prevention, Lianyungang

Pizhou County-Level City Center for Disease Control and Prevention, Xuzhou

Baoying County Center for Disease Control and Prevention, Yangzhou

Chaoyang Distinct Center for Disease Control and Prevention, Beijing

All Listed Sponsors
collaborator

Bejing Vigoo Biological Co., LTD

INDUSTRY

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT01508247 - A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months | Biotech Hunter | Biotech Hunter